Uncategorized

News Release October 17th, 2019 Bethesda, MD: The third annual Geroscience Summit was organized by the Trans-NIH Geroscience Interest Group (GSIG). The Geroscience Summit is hosted by the National Institute of Health, and brings together interdisciplinary experts in the field of age-related diseases to bring their expertise to the field of geroscience. Geroscience seeks interdisciplinary experts in age-related diseases Geroscience is an emerging field that recognizes aging as the greatest risk factor for most chronic diseases and disabilities that affect older adults. This field’s mission is to first understand how aging allows for these diseases, then determine how to slow the progression of them. Traditional medicine generally specializes based on a single disease. For example, a cardiologist treats heart disease, and a dermatologist treats skin disease. However, the scientific community now believes diverse, age-associated diseases are caused by common underlying pathways. Even so, different disciplines don’t communicate with each other.…

News Release November 13, 2019 London, England: This year, the Global Innovation and New Technology (GIANT) Health Event took place on October 15 – 16 in London. This event brought thousands of pioneers among the health tech industry. Among them was Dr. Kelsey Moody, CEO at Ichor Life Sciences. Lysoclear develops a therapy to treat age-related macular degeneration Dr. Moody presented a talk titled “Towards enzyme augmentation therapy for macular degeneration.” During his presentation, Dr. Moody discussed recent progress at Lysoclear, an Ichor portfolio company. Lysoclear is developing an enzyme therapy to treat both age-related macular degeneration and Stargardt’s disease. Today, more than 200 million people worldwide are affected by these diseases. In 2018, Lysoclear demonstrated proof of concept that lipofuscin — a product of cell aging that is a risk factor for age-related macular degeneration — can be removed from the eye using enzyme therapy. This approach could establish…

News Release November 13, 2019 LaFayette, N.Y. — The American Association for Laboratory Animal Science‘s (AALAS) National Meeting is the largest meeting in the world dedicated to the care, production, and use of laboratory animals. This year Ichor was represented by Dr. Danique Wortel, DVM, attending veterinarian, and Dr. Forrest Wright, PhD, Operations Manager of Husbandry. Caring for aging mice presents unique challenges Dr. Wortel spoke on a panel hosted by The Jackson Laboratory (Jax). Her talk, titled “Managing Methuselah Mice: Adapting for the Aged,” focused on the unique challenges presented by caring for aging populations of mice. “Methuselah mice” is a reference to Methuselah — a Biblical figure said to have lived the longest of all individuals mentioned in the Bible. Research on geriatric animals is a growing focus area for companies and academic laboratories studying aging. Ichor and Jax are leaders in research involving aged animals. Dr. Wortel…

News Release NEW YORK, NY: The second annual Life Extension Advocacy Foundation (LEAF) Ending Age Related Diseases Conference was held in New York City July 11-12th. This conference brought together many of the top minds in the biotechnology rejuvenation field, including Dr. Kelsey Moody, CEO at Ichor Therapeutics, Inc. Dr. Moody also held a workshop prior to the conference, on July 10th. The workshop was held in the Cooper Union Square as two 1.5-hour sessions. Here, he discussed some of the main elements to developing and maintaining a successful biotechnology company, specifically in the aging field. Dr. Moody has grown Ichor from a living room laboratory into a thriving business with multiple portfolio companies since its creation in 2013. At this workshop, essential tips and key information were shared with attendees regarding how to start and maintain a prosperous business in this industry. This included mechanisms necessary to grow a…

News Release LaFayette, N.Y. —The State University of New York College of Environmental Science and Forestry (ESF) and Ichor Life Sciences (formerly Ichor Therapeutics) are partnering to train graduate students in researching drugs that could combat age-related illnesses. The educational component will occur at ESF, where students will focus on biochemistry, chemistry or bioprocess engineering. Their laboratory research will primarily occur at the facilities of Ichor Life Sciences in nearby LaFayette, New York. Ichor Life Sciences is a premium pre-clinical contract research organization offering services in discovery through pharmacology. The scientific study of human aging has exploded in recent years, driven by a growing understanding of age-related disease and associated molecular pathways. The use of drugs for targeted purposes, such as selectively destroying toxic senescent (aging) cells, has been identified as a method for increasing mammalian lifespan. This has led to a demand for qualified post-graduate-level scientists to support emerging…

News Release Philadelphis, Pa. and LaFayette, N.Y. — Today, Ship of Theseus, LLC, a bioengineering company that focuses on stem cell therapies for aging and age-associated disease, announces the initiation of a murine lifespan study to be conducted at Ichor Life Sciences, (formerly Ichor Therapeutics). This work will inform new targets for therapeutic intervention in aging. Ship of Theseus was founded to drastically extend the lifespans of our loved ones alive today. To meet our clinical deadlines, we invest intensively in validation of not only our specific technologies, but also our overarching paradigms, with robust and thorough studies. Our lifespan work with Ichor exemplifies this dedication and our mutual commitment to scientific rigor and agility make us ideal partners. – Jeremy Elser, Ph.D, CEO Ship of Theseus LLC Supplementing age-diminished bone marrow is known to extend lifespan in rodents. Translation to humans, however, has been precluded by immune rejection of…